TMCnet News
Kite Pharma to Report First Quarter 2016 Financial Results on May 9, 2016Kite Pharma, Inc., (Nasdaq:KITE) today announced that it will report first quarter 2016 financial results on Monday, May 9, 2016 after market close. The announcement will be followed by a live audio webcast and conference call at 4:30 PM Eastern Time (1:30 PM Pacific Time). Audio Webcast The webcast will be made available on the Company's website at www.kitepharma.com under the Investors tab in the Events and Presentations section. Following the live audio webcast, a replay will be available on the Company's website for approximately 30 days. Dial-In Information
Live (U.S. / Caada): (877) 301-8565 Confirmation number: 89570152 About Kite Pharma Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA (News - Alert). For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter (News - Alert) at www.twitter.com/kitepharma.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160503007013/en/ |
